Adipose tissue-derived mesenchymal stem cell-based liver gene delivery.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Hepatology

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jhep.2010.07.051PMID 21168381PMCID PMC3079008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

  2011cited by this paper
• Hepatocyte Transplantation

  2009cited by this paper
• Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

  2009cited by this paper
• Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy

  2009cited by this paper
• Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

  2009cited by this paper
• Expression of liver‐specific markers in naïve adipose‐derived mesenchymal stem cells

  2009cited by this paper
• Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors

  2009influential reference
• Clinical gene therapy using recombinant adeno-associated virus vectors

  2008cited by this paper
• Stem cells, cell transplantation and liver repopulation.

  2008cited by this paper
• Gene Therapy Using Adeno-Associated Virus Vectors

  2008cited by this paper
• Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

  2008cited by this paper
• Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses

  2008cited by this paper
• Adipose tissue‐derived mesenchymal stem cells as a source of human hepatocytes

  2007cited by this paper
• Isolation of multipotent stem cells from mouse adipose tissue.

  2007cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Characterization of a Bipartite Recombinant Adeno-Associated Viral Vector for Site-Specific Integration

  2007cited by this paper
• Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo.

  2007cited by this paper
• Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies

  2007cited by this paper
• Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles

  2007cited by this paper
• Adipose-derived stem cells for regenerative medicine.

  2007cited by this paper
• Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.

  2007cited by this paper
• In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA

  2007cited by this paper
• Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue

  2006cited by this paper
• Adeno-associated virus serotypes: vector toolkit for human gene therapy.

  2006cited by this paper
• Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno‐associated virus (rAAV1) vector

  2006cited by this paper
• Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers

  2006cited by this paper
• Autologous Human Fat Grafting: Effect of Harvesting and Preparation Techniques on Adipocyte Graft Survival

  2006cited by this paper
• AAV transcytosis through barrier epithelia and endothelium.

  2006cited by this paper
• Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

  2005cited by this paper
• Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector.

  2005cited by this paper
• Monocrotaline, an Alternative to Retrorsine-Based Hepatocyte Transplantation in Rodents

  2005influential reference
• Hepatocyte transplantation

  2005cited by this paper
• Adeno-associated virus: from defective virus to effective vector

  2005cited by this paper
• α1-Antitrypsin deficiency · 6: New and emerging treatments for α1-antitrypsin deficiency

  2004cited by this paper
• Hepatocyte transplantation.

  2004cited by this paper
• Ex Vivo transduced liver progenitor cells as a platform for gene therapy in mice

  2004cited by this paper
• Gastric Cancer Originating from Bone Marrow-Derived Cells

  2004cited by this paper
• Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

  2004cited by this paper
• α1-Antitrypsin deficiency · 2: Genetic aspects of α1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk

  2004cited by this paper
• Hepatocyte transplantation

  2004cited by this paper
• α1-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding

  2004cited by this paper
• In vitro hepatic differentiation of human mesenchymal stem cells

  2004cited by this paper
• Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue

  2004cited by this paper
• Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk.

  2004cited by this paper
• alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

  2004cited by this paper
• alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.

  2004cited by this paper
• Route of hepatocyte delivery affects hepatocyte engraftment in the spleen.

  2003cited by this paper
• Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow

  2003cited by this paper
• Mouse A6–positive hepatic oval cells also express several hematopoietic stem cell markers

  2003cited by this paper
• Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

  2003cited by this paper
• Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects.

  2002cited by this paper
• Alpha1-antitrypsin deficiency--a model for conformational diseases.

  2002cited by this paper
• Human adipose tissue is a source of multipotent stem cells.

  2002cited by this paper
• Effect Of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle

  2001cited by this paper
• CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in Mice

  2001cited by this paper
• Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

  2001cited by this paper
• Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.

  2000cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Bone marrow as a potential source of hepatic oval cells.

  1999cited by this paper
• Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.

  1998cited by this paper
• Animal Model Long-Term, Near-Total Liver Replacement by Transplantation of Isolated Hepatocytes in Rats Treated with Retrorsine

  1998cited by this paper
• Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.

  1998cited by this paper
• Studies of liver repopulation using the dipeptidyl peptidase IV‐deficient rat and other rodent recipients: Cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule

  1996cited by this paper
• Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents.

  1996cited by this paper
• A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease.

  1996cited by this paper
• A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, Maryland

  1996cited by this paper
• Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.

  1991cited by this paper
• Characterization of the core promoter and enhancer of duck hepatitis B virus.

  1991cited by this paper
• The alpha 1-antitrypsin gene and its deficiency states.

  1989cited by this paper
• The α1-antitrypsin gene and its deficiency states

  1989cited by this paper
• The human alpha 1‐antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes.

  1987cited by this paper
• The isolation of a clone for human α 1-antitrypsin and the detection of α 1-antitrypsin in mRNA from liver and leukocytes

  1983cited by this paper
• The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes.

  1983cited by this paper

• Alpha 1 Antitrypsin Suppresses Autoantibody Production and Cellular Autoimmunity in Chronic Graft-Versus-Host Disease (cGVHD) in a Lupus Mouse Model

  2026cites this paper
• Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases

  2023cites this paper
• EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment

  2022cites this paper
• Adipose mesenchymal stem cell sheets-derived extracellular vesicles-microRNA-10b promote skin wound healing by elevating expression of CDK6.

  2022cites this paper
• Effects of chitosan-glycerol phosphate hydrogel on the maintenance and homing of hAd-MSCs after xenotransplantation into the rat liver

  2021cites this paper
• Stem Cells and Hydrogels for Liver Tissue Engineering: Synergistic Cure for Liver Regeneration

  2020cites this paper
• Overexpression of alpha‐1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice

  2020cites this paper
• Advances in Alpha-1 Antitrypsin Gene Therapy.

  2020cites this paper
• Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency

  2019cites this paper
• Alpha-1-Antitrypsin Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice

  2019cites this paper
• Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV).

  2018cites this paper
• Shock wave-induced permeabilization of mammalian cells.

  2018cites this paper
• Mesenchymal stem cells as the game‐changing tools in the treatment of various organs disorders: Mirage or reality?

  2018cites this paper
• Treatment of Hepatic Malignances and Disorders: The Role of Liver Bioengineering

  2017cites this paper
• Oncostatin M and TNF-α Induce Alpha-1 Antitrypsin Production in Undifferentiated Adipose Stromal Cells

  2017cites this paper
• Transplantation of Adipose Tissue–Derived Mesenchymal Stem Cell (ATMSC) Expressing Alpha-1 Antitrypsin Reduces Bone Loss in Ovariectomized Osteoporosis Mice

  2017influential citation
• Reprogrammed Cell‐based Therapy for Liver Disease: From Lab to Clinic

  2017cites this paper
• Investigating Genetic Risk Factors of Coronary Artery Disease Using Genome Editing

  2016cites this paper
• Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis

  2016cites this paper
• Spheroid Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Microvesicles: Two Potential Therapeutic Strategies

  2016cites this paper
• In Situ Transplantation of Alginate Bioencapsulated Adipose Tissues Derived Stem Cells (ADSCs) via Hepatic Injection in a Mouse Model

  2015cites this paper
• Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

  2015cites this paper
• Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy

  2015influential citation
• Gene delivery in tissue engineering and regenerative medicine.

  2015cites this paper
• Manipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells

  2015cites this paper
• Translational Regenerative Medicine—Hepatic Systems

  2015cites this paper
• Impact of source tissue and ex vivo expansion on the characterization of goat mesenchymal stem cells

  2015cites this paper
• Cell-microsphere constructs formed with human adipose-derived stem cells and gelatin microspheres promotes stemness, differentiation, and controlled pro-angiogenic potential.

  2014cites this paper
• α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment.

  2014cites this paper
• Mice with humanized liver endothelium

  2014cites this paper
• Bioartificial Liver

  2014cites this paper
• In vitro processing of human bone marrow derived mesenchymal stem cells to enhance delivery in liver disease

  2013cites this paper
• Genetically Modified Adipose Tissue-Derived Stem/Stromal Cells, Using Simian Immunodeficiency Virus-Based Lentiviral Vectors, in the Treatment of Hemophilia B

  2013cites this paper
• Recent advances in α-1-antitrypsin deficiency-related lung disease

  2013cites this paper
• Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies

  2013cites this paper
• Hepatocyte Transplantation, ‘Omics’ and Gene Therapy in the Management of Liver Diseases

  2012cites this paper
• Cell therapies for liver diseases

  2012cites this paper
• Adipose tissue stem cells: the great WAT hope.

  2012cites this paper
• Prevalence and risk factors for liver involvement in individuals with PiZZ-related lung disease.

  2011cites this paper
• Alpha-1 Antitrypsin Deficiency: Recent Developments in Gene Therapy Research

  2011cites this paper
• Stem cells: Mesenchymal stem cells from adipose tissue could be used to deliver gene therapy to the liver

  2011cites this paper
• Gene therapy of liver diseases: a 2011 perspective.

  2011cites this paper
• Adipose-tissue derived hepatic stem cells for gene therapy: fat goes to liver's rescue?

  2011cites this paper